Angela M H Brodie

Title: The Innovative Contributions of Angela M H Brodie

Introduction

Angela M H Brodie is a distinguished inventor based in Fulton, MD (US). He is recognized for his significant contributions to the field of cancer treatment and dermatological diseases through his innovative research and patented inventions. His work has had a profound impact on the medical community, particularly in the development of retinoic acid analogs.

Latest Patents

Angela M H Brodie holds a patent for "C-4 substituted retinoids - C-4 substituted retinoic acid analogs, synthesis methods of C-4 substituted retinoic acid analogs and methods of using C-4 substituted retinoic acid analogs to treat various cancers and dermatological diseases and conditions." This patent includes C-4 all-trans retinoic acid (ATRA) and 13-cis retinoic acid (13-CRA) analogs. The C-4 substituted retinoic acid analogs inhibit ATRA 4-hydroxylase activity, thereby inhibiting the catabolism of ATRA. Additionally, these analogs exhibit ATRA-mimetic activity, which is crucial for their therapeutic applications.

Career Highlights

Angela M H Brodie is affiliated with the University System of Maryland, where he has made significant strides in research and development. His work has been pivotal in advancing the understanding of retinoic acid and its applications in treating various medical conditions. His innovative approach has garnered attention and respect within the scientific community.

Collaborations

Angela has collaborated with notable colleagues, including Vincent C O Njar and Ivo P Nnane. These collaborations have further enhanced the research and development of retinoic acid analogs, contributing to the advancement of cancer treatment methodologies.

Conclusion

Angela M H Brodie's innovative work in the field of retinoic acid analogs has made a significant impact on cancer treatment and dermatological conditions. His contributions continue to inspire future research and development in the medical field.